Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis von Jara, Michele, Sidovar, Matthew F, Henney, 3rd, Herbert R

Volltext

Mapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohort von Sidovar, Matthew F, Limone, Brendan L, Coleman, Craig I

Volltext

The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability von LaRocca, NG, Hudson, LD, Rudick, R, Amtmann, D, Balcer, L, Benedict, R, Bermel, R, Chang, I, Chiaravalloti, ND, Chin, P, Cohen, JA, Cutter, GR, Davis, MD, DeLuca, J, Feys, P, Francis, G, Goldman, MD, Hartley, E, Kapoor, R, Lublin, F, Lundstrom, G, Matthews, PM, Mayo, N, Meibach, R, Miller, DM, Motl, RW, Mowry, EM, Naismith, R, Neville, J, Panagoulias, J, Panzara, M, Phillips, G, Robbins, A, Sidovar, MF, Smith, KE, Sperling, B, Uitdehaag, BM, Weaver, J, Multiple Sclerosis Outcome Assessments Consortium (MSOAC)

Volltext

Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claimsanalysis von Jara M, Sidovar MF, Henney III HR

Volltext

Phosphorylation of Serine 43 Is Not Required for Inhibition of c-Raf Kinase by the cAMP-dependent Protein Kinase von Sidovar, M F, Kozlowski, P, Lee, J W, Collins, M A, He, Y, Graves, L M

Volltext